Proof Diagnostics

Cambridge, United States · Founded 2020

Founded
2020
Business Model
B2B

About

Proof Diagnostics is a healthcare technology company developing a CRISPR-based molecular diagnostic platform for rapid, lab-quality point-of-care testing. Founded in May 2020 by CRISPR pioneers Feng Zhang, Omar Abudayyeh, and Jonathan Gootenberg alongside entrepreneur Sid Shenai (CEO), the company licensed the STOPCovid CRISPR chemistry from the Broad Institute and engineered a portable smart reader capable of delivering results in as little as 18 minutes. The company has raised 45M from ARCH Venture Partners, F-Prime Capital, and Madrona Venture Group, with research support from NIH RADx, DARPA, and the Gates Foundation.

Summary

Proof Diagnostics is a Biotech company based in Cambridge, United States, founded in 2020.

Similar Companies